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Identification of a Novel Genomic Island Conferring Resistance to
Multiple Aminoglycoside Antibiotics in Campylobacter coli
Abstract
Historically, the incidence of gentamicin resistance in Campylobacter has been very low, but recent studies
reported a high prevalence of gentamicin-resistant Campylobacter isolated from food-producing animals in
China. The reason for the high prevalence was unknown and was addressed in this study. PCR screening
identified aminoglycoside resistance genes aphA-3 and aphA-7 and the aadE–sat4–aphA-3 cluster among 41
Campylobacter isolates from broiler chickens. Importantly, a novel genomic island carrying multiple
aminoglycoside resistance genes was identified in 26 aminoglycoside resistant Campylobacter coli strains.
Sequence analysis revealed that the genomic island was inserted between cadF and COO1582 on the C. coli
chromosome and consists of 14 open reading frames (ORFs), including 6 genes (the aadE–sat4–aphA-3
cluster, aacA-aphD, aac, and aadE) encoding aminoglycoside-modifying enzymes. Analysis by pulsed-field gel
electrophoresis (PFGE) and multilocus sequence typing indicated that the C. coli isolates carrying this
unique genomic island were clonal, and the clone of PFGE subtype III and sequence type (ST) 1625 was
particularly predominant among the C. coli isolates examined, suggesting that clonal expansion may be
involved in dissemination of this resistance island. Additionally, we were able to transfer this genomic island
from C. coli to a Campylobacter jejuni strain using natural transformation under laboratory conditions, and
the transfer resulted in a drastic increase in aminoglycoside resistance in the recipient strain. These findings
identify a previously undescribed genomic island that confers resistance to multiple aminoglycoside
antibiotics. Since aminoglycoside antibiotics are used for treating occasional systemic infections caused by
Campylobacter, the emergence and spread of this antibiotic resistance genomic island represent a potential
concern for public health.
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Identification of a Novel Genomic Island Conferring Resistance to
Multiple Aminoglycoside Antibiotics in Campylobacter coli
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Historically, the incidence of gentamicin resistance in Campylobacter has been very low, but recent studies reported a high prev-
alence of gentamicin-resistant Campylobacter isolated from food-producing animals in China. The reason for the high preva-
lence was unknown and was addressed in this study. PCR screening identified aminoglycoside resistance genes aphA-3 and
aphA-7 and the aadE–sat4–aphA-3 cluster among 41 Campylobacter isolates from broiler chickens. Importantly, a novel
genomic island carrying multiple aminoglycoside resistance genes was identified in 26 aminoglycoside resistant Campylobacter
coli strains. Sequence analysis revealed that the genomic island was inserted between cadF and COO1582 on the C. coli chromo-
some and consists of 14 open reading frames (ORFs), including 6 genes (the aadE–sat4–aphA-3 cluster, aacA-aphD, aac, and
aadE) encoding aminoglycoside-modifying enzymes. Analysis by pulsed-field gel electrophoresis (PFGE) andmultilocus se-
quence typing indicated that the C. coli isolates carrying this unique genomic island were clonal, and the clone of PFGE subtype
III and sequence type (ST) 1625 was particularly predominant among the C. coli isolates examined, suggesting that clonal expan-
sionmay be involved in dissemination of this resistance island. Additionally, we were able to transfer this genomic island from
C. coli to a Campylobacter jejuni strain using natural transformation under laboratory conditions, and the transfer resulted in a
drastic increase in aminoglycoside resistance in the recipient strain. These findings identify a previously undescribed genomic
island that confers resistance to multiple aminoglycoside antibiotics. Since aminoglycoside antibiotics are used for treating occa-
sional systemic infections caused by Campylobacter, the emergence and spread of this antibiotic resistance genomic island repre-
sent a potential concern for public health.
Campylobacter is one of the most common food-borne patho-gens worldwide. Two thermophilic species, Campylobacter je-
juni andCampylobacter coli, are responsible formostCampylobac-
ter infections in humans. BothC. jejuni andC. coli are prevalent in
food-producing animals, and the extensive use of antimicrobials
in food animal production has led to an increasing prevalence of
antibiotic-resistantCampylobacter strains, which can be transmit-
ted to humans via the food chain (1, 3).
Clinical therapy of Campylobacter-induced gastroenteritis,
when needed, is often conducted with macrolide and fluoroquin-
olone antibiotics, but severe systemic infections, which occur spo-
radically, requires the use of an aminoglycoside antibiotic, such as
gentamicin (2). Aminoglycosides are highly potent, broad-spec-
trum, bactericidal antibiotics and are commonly used in the
treatment of infections caused by both Gram-negative and Gram-
positive organisms in humans (25). Additionally, several amin-
oglycoside agents, such as neomycin and amikacin, are also used
in conventional broiler chicken and swine production in some
countries, including China. Among the known mechanisms of
aminoglycoside resistance, enzymatic modification is the most
important and prevalent one in several bacterial species, including
Campylobacter spp. (17, 25). Based on the reactions they catalyze,
aminoglycoside-modifying enzymes are divided into three
groups: aminoglycoside acetyltransferases (AACs), aminoglyco-
side nucleotidyltranferases (ANTs), and aminoglycoside phos-
photransferases (APHs) (17). In Campylobacter, each group of
aminoglycoside-modifying enzymes has been detected. The 3=,9-
aminoglycoside adenyltransferase gene (aadA) and 6-aminogly-
coside adenyltransferase gene (aadE) confer resistance to strepto-
mycin; the aacA4 gene, encoding an AAC, confers resistance to
gentamicin and tobramycin (11, 15), and 3=-APHs, which are the
most frequently reported, are responsible for resistance to kana-
mycin and neomycin (30).
The aminoglycoside resistance genes in Campylobacter have
been detected on multidrug-resistant plasmids, integrons, and
transposons (9, 13). In addition, the aminoglycoside resistance
gene cluster, aadE–sat4 –aphA-3, has been detected on trans-
missible plasmids in C. jejuni but has not been identified in C.
coli (9, 13). Although kanamycin resistance has been reported
in multiple studies, the prevalence of gentamicin-resistant
Campylobacter is generally low (1%) in studies from various
countries (3, 12, 27). However, two recent studies conducted in
China indicated that the frequency of aminoglycoside resis-
tance, especially gentamicin resistance, is high (20%) in C.
coli isolated from both broiler chickens and swine (4, 16). The
resistance mechanisms and the reason for the high prevalence
of gentamicin-resistant Campylobacter in China are not
known. To answer these questions, we analyzed aminoglyco-
side-resistant Campylobacter isolates derived from chickens
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and identified a unique genetic structure containing multiple
aminoglycoside resistance genes, including aadE–sat4 –aphA-3
and aacA-aphD, on the chromosome of C. coli. This novel
chromosomal aminoglycoside resistance gene cluster has not
been reported previously and is associated with clonal isolates
of C. coli, suggesting the possibility of clonal expansion of ami-
noglycoside-resistant C. coli in broiler chickens in China. Fur-
thermore, we demonstrated the potential dissemination of this
unique genetic structure from C. coli to C. jejuni under labora-
tory conditions. These findings provide new insights into the
dissemination of aminoglycoside resistance in Campylobacter.
MATERIALS AND METHODS
Campylobacter strains and susceptibility testing. In total, 138 Campy-
lobacter isolates (C. jejuni, n  90; C. coli, n  48), derived from two
broiler chicken slaughterhouses located in eastern (Penglai) and west-
ern (Shenxian) regions of Shandong province, were used in this study.
Detailed information on their susceptibilities to various antimicrobi-
als (including gentamicin) is provided in a previous publication (4). In
this study, the isolates were further examined for their susceptibility to
kanamycin, neomycin, and amikacin using the agar dilution method,
according to the guideline M31-A3 of the Clinical and Laboratory
Standards Institute (CLSI) (5). The reference strain C. jejuni ATCC
33560 was used as a quality control strain. The breakpoint for kana-
mycin is 64 g/ml according to the CLSI (5). Since there are no CLSI
breakpoints for neomycin and amikacin in Campylobacter, we used the
breakpoints of the two agents for Enterobacteriaceae, which are 32
g/ml and 64 g/ml, respectively (5, 26).
Detection of aminoglycoside resistance genes andmolecular analy-
sis.All kanamycin-resistant strains were selected to investigate the known
aminoglycoside resistance genes aphA-1, aphA-3, and aphA-7 and the
aadE-sat4-aphA-3 gene cluster, which were previously found in Campy-
lobacter (9, 14, 22). The primers used to detect the aphA-3 gene and aadE-
sat4-aphA-3 gene cluster were described previously (9), and the primers
designed for the amplification of aphA-1 (aphA-1-F, 5=-CGTATTTCGT
CTCGCTCAG-3=; aphA-1-R, 5=-CCGACTCGTCCAACATCA-3=) and
aphA-7 (aphA-7-F, 5=-ATCCGATAAACTGAAAGTAC-3=; aphA-7-R,
5=-ATAATCCGGTTCAAGTCCC-3=) were based on previously pub-
lished sequences (14, 22). Genomic DNA was isolated from the strains
using a Wizard genomic DNA purification kit (Promega, Madison, WI).
Plasmid DNA was extracted using a Qiagen plasmid extraction midikit
(Qiagen, Hilden, Germany). Southern blotting was conducted to deter-
mine the location of the aadE–sat4–aphA-3 gene cluster; the primers spe-
cific for the gene cluster (CF, 5=-GGATGGATTCCTATGAAAACAT-3=;
CR, 5=-GGCTTTGTTCATCTTCATACTCT-3=) were designed according
to previously published sequences (9), and the PCR product was used as
the probe for hybridization. The probe was nonradioactively labeled with
a DIG High Prime I DNA labeling and detection starter kit (Roche Diag-
nostics, Mannheim, Germany). Hybridization was performed at 42°C for
14 h. Membranes were washed twice at room temperature (22 to 25°C) in
2 SSC (1 SSC is 0.15 MNaCl plus 0.015M sodium citrate), 0.5% SDS
for 5 min and twice at 68°C in 0.1 SSC, 0.5% SDS for 15 min. DIG was
detected with specific antibodies using a DIG High Prime I DNA labeling
and detection starter kit (Roche Diagnostics, Mannheim, Germany) ac-
cording to the recommendations of the supplier. In addition, the flanking
regions of the gene cluster were sequenced by a modified random primer
sequencing walking strategy as described previously (29).
Pulsed-field gel electrophoresis (PFGE). PFGE was performed using
a CHEF-DR III apparatus (Bio-Rad Laboratories, Hercules, CA), accord-
ing to the rapid protocol for Campylobacter (18). Salmonella H9812 was
used as the referencemarker (digestedwithXbaI), while allCampylobacter
isolates were digested with SmaI. The running conditions were as follows:
0.5 Tris-borate-EDTA–1% SeaKem Gold agarose (FMC BioProducts,
Rockland, ME) at 14°C and 6 V/cm for 18 h with switch times ranging
from 6.75 s to 38.35 s and an included angle of 120°. The dendrograms
were constructed from the PFGE data by UPGMA (unweighted pair
groupmethodwith arithmetic average) with theDice coefficient using the
InfoQuest FP software version 4.5 (Bio-Rad Laboratories).
Multilocus sequence typing (MLST).MLST of the seven housekeep-
ing genes (aspA, glnA, gltA, glyA, pgm, tkt, and uncA) for C. coli was per-
formed following the method described previously (7). Briefly, all the
housekeeping geneswere amplified, and the PCRproducts were run on an
agarose gel to confirm the correct amplicon size and then purified using a
Tiangen purification midikit following the manufacturer’s instructions
(Tiangen, Beijing, China). All purified products were sent to the Beijing
Genomic Institute (BGI) for sequencing using the forward and reverse
primers of these genes. The allelic profiles and the sequence types were
generated by carrying out a BLAST search with the Campylobacter se-
quences in theMLSTdatabase (http://www.pubmlst.org/campylobacter).
Natural transformation. A transformation assay using Mueller-Hin-
ton agar was performed according to the method described byWang and
Taylor with minor modifications (28). Genomic DNAs purified from
aminoglycoside-resistant C. coli strains served as the donors, while amin-
oglycoside-sensitive C. jejuni NCTC11168 was used as the recipient.
Briefly, fresh recipient cells (20- to 24-h growth onMueller-Hinton [MH]
agar, grown microaerobically at 42°C) were spread on MH agar at about
5 107 cells per plate (in triplicate) and incubated for 6 h (microaerobi-
cally at 42°C). Subsequently, 1g of genomicDNAof the donor strainwas
spotted directly onto the inoculated agar, without additional spreading,
and incubation was continued for 5 h at 42°C under microaerobic condi-
tions. The cells were harvested from theMH agar and plated on a selective
MH agar plate containing kanamycin (60 g/ml) (KMHA), which was
further incubated for 48 to 72 h at 42°C under microaerobic conditions.
The recipient (without donor DNA) inoculated on the same MH agar
plate served as a negative control. Transformants on the KMHA plates
were selected and confirmed by PCR. The stability of aminoglycoside
resistance in the transformants was investigated using the method re-
ported by Kim et al. (10).
Nucleotide sequence accession number. The sequence of the novel
gene cluster described in this paper has been submitted toGenBank under
accession number JQ655275.
RESULTS
Characterization of aminoglycoside resistance in Campylobac-
ter. Among the 138 Campylobacter isolates tested (C. jejuni, n 
90;C. coli, n 48), 41 (29.7%, including 5 C. jejuni and 36C. coli)
were resistant to both kanamycin (MIC  256 g/ml) and neo-
mycin (MIC 32 g/ml), and 36 (26%, including 2 C. jejuni and
34 C. coli) were resistant to amikacin (MIC  64 g/ml). All 36
amikacin-resistant isolates were also resistant to both kanamycin
and neomycin. The prevalence of resistance to the tested amin-
oglycosides was significantly higher in C. coli (71%) than in C.
jejuni (5.6%) (P  0.01). Over half of the kanamycin-resistant
isolates (65.9%, 26/41) harbored the aadE–sat4–aphA-3 cluster,
and all of them were C. coli. In addition, all these aadE–sat4–
aphA-3-carrying C. coli isolates were resistant to gentamicin. The
other 15 kanamycin-resistant isolates harbored only either
aphA-7 or aphA-3 and were not resistant to gentamicin. The
aphA-7 gene was present only in the Campylobacter isolates from
Shenxian, including 2 C. jejuni and 10 C. coli isolates. The single
aphA-3 gene was observed only in three C. jejuni strains, one from
ShenxianandtwofromPenglai.NoaphA-1genewasdetectedamong
the kanamycin-resistant isolates. The distribution of kanamycin re-
sistance genes inCampylobacter is summarized in Table 1.
Genotyping.To facilitate understanding of the transmission of
the aminoglycoside resistance genes, the genetic diversity of the 36
aminoglycoside-resistant C. coli isolates that harbored aphA7 or
Aminoglycoside Resistance in Campylobacter coli
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the aadE–sat4–aphA-3 cluster was determined by PFGE using
SmaI digestion (Fig. 1). Using a cutoff of 90% genetic similarity,
the isolates were clustered into 5 PFGE subtypes, with subtype III
accounting for the majority (21/36) of the isolates. Subtypes I, II,
and III harbored the aadE–sat4–aphA-3 cluster (n  26), while
subtypes IV and V carried the aphA7 gene. The high genetic sim-
ilarity (95%) of the 21 isolates (subtype III) (Fig. 1) that all
originated from Penglai (MH strains) suggested that these isolates
might have originated from a single clone. However, the isolates
from Shenxian (SX strains) exhibited four different PFGE sub-
types (I, II, IV, and V).
Twelve aminoglycoside-resistant isolates representative of
all the PFGE subtypes and four aminoglycoside-susceptible
isolates (SX71, SX73, MH16, and MH25) were selected for
MLST typing. The results identified six sequence types (STs)
(Table 2). Four STs were identified for the aminoglycoside re-
sistant isolates: ST 5604 (SX30, SX108 and SX114 in PFGE
subtype I), ST 1586 (SX81 in PFGE subtype II), ST 1625 (MH4,
MH34, MH57 and MH62 in PFGE subtype III), and ST 5510
(SX94, SX117, and SX58 in PFGE subtype IV; SX1 in PFGE
subtype V). ST 5604 represents a newly identified ST and is first
reported in this study. In general, each PFGE subtype corre-
sponds to a single ST, indicating the consistency of the two
typing methods. Notably, all of the typed aminoglycoside re-
sistant isolates belong to clonal complex 828 (Table 2). Two
TABLE 1 Distribution of kanamycin resistance determinants in Kmr
isolates detected by PCR
Kanamycin resistance gene(s) Species
No. of Kmr isolates:
SX (n 18) MH (n 23)
aphA-1 C. jejuni 0 0
C. coli 0 0
aphA-3a C. jejuni 1 2
C. coli 0 0
aphA-7 C. jejuni 2 0
C. coli 10 0
aadE–sat4–aphA-3 C. jejuni 0 0
C. coli 5 21
a The isolates harbored only aphA-3 (strains harboring aphA-3 as part of aadE-sat4-
aphA3 were not included in this category).
FIG 1 PFGE-based dendrogram for 36 kanamycin-resistant C. coli strains harboring the aphA-7 gene or the aadE–sat4–aphA-3 gene cluster.
Qin et al.
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STs were found for the typed aminoglycoside-susceptible iso-
lates, including ST 4248 (SX71 and SX73) and ST 4268 (MH16
and MH25), whose clonal complexes have not been assigned.
Identification of a novel aminoglycoside resistance gene is-
land.Three isolates harboring the aadE–sat4–aphA-3 gene cluster
(SX81, MH57, and SX114), which belonged to three different
PFGE subtypes (Fig. 1) and three different ST types (Table 2), were
selected for further genetic analysis. No plasmids were obtained
from these isolates by extraction using the Qiagen plasmid extrac-
tionmidikit and theWizard Plus SVminiprep purification system
(Promega), suggesting that the resistance genes were not carried
by plasmids. Southern blotting of PFGE-separated DNA of all
tested strains indicated that the aadE–sat4–aphA-3 cluster was
located on large chromosomal DNA fragments digested by SmaI
(Fig. 2). The surrounding genetic environment of the aadE–sat4–
aphA-3 cluster in SX81 was sequenced by a modified random
primer walking strategy, starting from the aadE gene and the
aphA-3 gene. A 15.3-kb segment of the chromosome was se-
quenced and was found to contain 16 open reading frames
(ORFs), including the aadE–sat4–aphA-3 cluster (Fig. 3; Table 3).
A unique segment of 14 ORFs, including several antimicrobial
resistance genes [six genes encoding aminoglycoside-modifying
enzymes and a truncated tet(O) gene], was inserted between the
cadF gene and the CCO1582 gene in the chromosomal DNA of C.
coli SX81. In the sequenced genome of C. coli RM2228 (7), the
CCO1583 gene is located between cadF and CCO1582. A similar
genetic organization was also observed in C. jejuni (Fig. 3). How-
ever, the gene CCO1583 (or cj1477c in C. jejuni) was replaced by
the 14-ORF segment in C. coli SX81. Additionally, the GC con-
tent for this 14-gene cluster is 37.3%, which is significantly higher
than that (31.4%) of the entire genome of C. coli RM2228. These
results indicate that C. coli SX81 has acquired a genomic island of
14 ORFs inserted between cadF and COO1582 on the chromo-
some.
The annotation of the 14-gene island, including the flanking
genes cadF and CCO1582, is shown in Table 3. Among the six
genes encoding aminoglycoside-modifying enzymes in this clus-
ter, sat4 and aphA-3 in the aadE–sat4–aphA-3 cluster show 100%
nucleotide identity with their homologs in pCG8245 (13), a mul-
tidrug-resistant plasmid identified in C. jejuni. The aadE gene in
the aadE–sat4–aphA-3 cluster of SX81 is 702 bp, encoding a full-
length protein that is 97% identical (amino acids) to the homolog
in Enterococcus faecalis. However, the aadE homolog in pCG8245
was truncated (only 516 bp long) andwas not functional (13). The
aac gene located immediately downstream of cadF in SX81
showed only 47.2% nucleotide identity to the aac gene in
pCG8245, although they have the same length (13). The aac gene
in SX81 encodes an acetyltransferase enzyme that shows 100%
amino acids identity to its homolog in E. faecalis T2. The aacA-
aphD gene encodes a protein of 479 amino acids that has 100%
identity to the bifunctional aminoglycoside-modifying enzyme
AacA-AphD in Staphylococcus aureus. However, the aacA (aphD)
gene in SX81 exhibits only 47.7% nucleotide identity to the ho-
molog in pCG8245. Furthermore, the aacA-aphD gene in
pCG8245 was truncated and encodes only 281 amino acids (13).
To determine whether this unique genomic island exists in the
other two aadE–sat4–aphA-3 cluster-containing C. coli strains
(SX114 andMH57), a long-range PCR assay was conducted using
a Premix LA Taq version 2.0 kit (TaKaRa, Dalian, China) and
primers cadf-F (5=-GCTCAAGCAATGACACTAAAG-3=) and
pfo-R (5=-GGAGAACTAGGTGTAATAGGAT-3=), which are lo-
cated in the conserved regions of the cadF and COO1582 genes,
respectively. An amplicon of 10.6 kb was obtained from both
SX114 and MH57 (Fig. 4), and sequencing results showed that it
was identical to that in SX81 (data not shown). Furthermore, this
unique structure was also detected in the other 23 aadE–sat4–
aphA-3 cluster-harboring C. coli isolates using the above-men-
tioned PCR assays (data not shown). In contrast, the examined
aminoglycoside susceptible isolates SX71, SX73, and MH16 did
not yield this 10.6-kb fragment but showed a 908-bp fragment
TABLE 2 Aminoglycoside susceptibility, ST, clonal complex, and PFGE
pattern of C. coli strains from broiler chickens
Aminoglycoside susceptibility Strains ST
Clonal
complex
PFGE
pattern
Resistant SX114 5604 828 I
SX30 5604 828 I
SX108 5604 828 I
SX81 1586 828 II
MH57 1625 828 III
MH62 1625 828 III
MH34 1625 828 III
MH4 1625 828 III
SX94 5510 828 IV
SX117 5510 828 IV
SX58 5510 828 IV
SX1 5510 828 IV
Susceptible SX71 4248 —a NDb
SX73 4248 — ND
MH16 4268 — ND
MH25 4268 — ND
a —, not assigned.
b ND, not determined.
FIG 2 (A) PFGE plugs of kanamycin-resistantC. coli SX81, SX114, andMH57
digested with SmaI; (B) Southern hybridization of the aadE–sat4–aphA-3
cluster to genomic DNA of these isolates. Lane 1, NCTC11168; lane 2, ATCC
33559; lane 3, SX81; lane 4, SX114; lane 5, MH57; lane M, DNA standards.
Aminoglycoside Resistance in Campylobacter coli
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(Fig. 4), which was determined to be the CCO1583 gene by se-
quencing. Additionally, PCR testing of the kanamycin-resistant
isolates that harbored only aphA-7 or aphA-3 did not identify the
14-gene cluster.
Transfer of aminoglycoside resistance via natural transfor-
mation. Campylobacter is naturally transformable by taking up
DNA from the environment. As the unique aminoglycoside-resis-
tant genomic island is inserted into the chromosome ofC. coli and
is not associated with a plasmid or transposable element, we ex-
amined if the gene cluster can be transferred toC. jejuni by natural
transformation under laboratory conditions. The genomic DNAs
of the three C. coli strains (SX81, MH57, and SX114) were used as
the donor DNA, and C. jejuniNCTC11168 was used as the recip-
ient strain. With each donor DNA, aminoglycoside resistant
transformants were obtained. A 10.6-kb fragment was amplified
using the primers cadf-F and pfo-R from the transformants
FIG 3 Genomic organization of the aminoglycoside resistance island in C. coli SX81 in comparison with plasmid pCG8245 and chromosomal genes of C. coli
RM2228. Arrows indicate the positions and directions of transcription of the genes. Homologous genes in the three fragments are displayed with the same types
of shading. The locations of primers cadf-F and pfo-R used to detect the unique genomic island are indicated.
TABLE 3 Annotation of genes in the genomic island flanked by cadF and cco1582 in C. coli SX81
Gene or ORF
Coding region
(bp)
GC content
(%)
Length
(aa)a
Length
(aa)b
% Identity/% positive
(no. of aa) Annotation and/or accession no.
cadF 121–1119 34.5 332 332 99/99 (332) Fibronectin-binding protein, Campylobacter coli
JV20; ZP_07401432
aac 1133–1498 24.9 121 121 100/100 (121) Acetyltransferase, Enterococcus faecalis T2;
ZP_05426921
aacA-aphD 1499–2938 24.7 479 479 100/100 (479) Bifunctional aminoglycoside modifying enzyme
AacA-AphD, Staphylococcus aureus; NP_863643
orf1 2996–3112 19.7 38 Unknown (no significant match in database)
aadE 3204–3902 37.4 233 225 97/97 (225) Streptomycin aminoglycoside 6-adenyltransferase,
Enterococcus faecalis D6; EEU82268
sat4 3914–4444 37.9 176 176 100/100 (176) Streptothricinacetyltransferase, Enterococcus
faecium; ZP_05674679.1
aphA-3 4537–5331 44.9 264 264 100/100 (264) Aminoglycoside phosphotransferase type III,
Enterococcus faecalis; YP_783930
orf2 5439–6105 44.4 224 199 80/82(199) Hypothetical protein BSEG_01714, Bacteroides
dorei 5_1_36, D4; EEO45573
orf3 6127–6550 41.3 150 141 99/99 (141) Hypothetical protein BSEG_01715, Bacteroides
dorei5_1_36, D4; EEO45574
pcp 6620–6913 51.2 139 97 100/100 (97) Pyrrolidone carboxylate peptidase, Bacteroides sp.
9_1_42FAA; ZP_04541315
orf4 7067–7495 31.7 132 120 95/98 (120) Hypothetical protein, Streptococcus suis;
CBZ42064
orf5 7527–7871 42.0 181 104 98/100 (104) Unknown, Campylobacter jejuni; AAW34157
aadE 8249–9115 35.4 288 288 99/99 (288) Putative adenyltransferase, Pediococcus acidilactici;
YP_001965484
orf6 9203–9720 58.9 196 172 88/89(172) Hypothetical protein CLONEX_02761,
Clostridium nexile DSM 1787; EEA81276
tet(O) 9735–11096 39.2 639 449 100/100 (449) Tetracycline resistance protein, Campylobacter coli
RM2228; ZP_00371083
CCO1582 11568–15128 35.3 1186 1186 99/99 (1186) Pyruvate ferredoxin/flavodoxin oxidoreductase
family protein, Campylobacter coli RM2228;
ZP_00368185
a Size of the ortholog protein. aa, amino acids.
b Length of the SX81 peptide.
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(Fig. 4), and DNA sequencing confirmed that the PCR products
contained the unique 14-gene cluster, indicating that this genomic
island is transferable toC. jejuni 11168 by natural transformation.
The MICs of streptomycin, kanamycin, gentamicin, neomycin,
and amikacin in the recipient, donors, and transformants are
summarized in Table 4. Compared to the recipient strain, the
transformants showed drastically increased MICs of the five tested
aminoglycosides, which were comparable to the MICs in the donor
strains. This result suggests that once transferred toC. jejuni, the 14-
gene cluster confer a high-level resistance to aminoglycoside antibi-
otics. Additionally, passage of the transformants in antibiotic-free
medium indicated that the acquired resistance and the 14-gene clus-
ter remained stable after 14 passages (data not shown).
DISCUSSION
In the present study, a previously undescribed genomic island
containing 14ORFs and conferring aminoglycoside resistancewas
identified in C. coli isolates derived from broiler chickens. This
island is inserted between cadF and COO1582 on the C. coli chro-
mosome and has a GC content significantly higher than that of
the entireC. coli genome. The conclusion that the aminoglycoside
resistance island is located on chromosome is based on the follow-
ing findings. First, no plasmids were isolated from the examined
C. coli isolates. Second, the resistance island was found to be in-
serted between chromosomally located genes cadF and CCO1582,
which are highly conserved on C. coli and C. jejuni genomes and
have not been found on any plasmids. Third, the aadE–sat4–
aphA-3 cluster-specific probe hybridized to large SmaI-digested
genomic fragments in SX81, SX114, and MH57 (280 kb,370
kb, and 500 kb, respectively) (Fig. 2). Additionally, this resis-
tance island can be readily transferred to C. jejuni via natural
transformation, and the genomic location of the transferred resis-
tance genes was further confirmed by long-range PCR (Fig. 4) and
sequence analysis. As transfer of large plasmids to C. jejuni by
natural transformation is quite difficult, its ease of transfer by
natural transformation also suggests a chromosomal location of
the resistance island. Together, these data indicate that this amin-
oglycoside resistance gene cluster represents a genomic island in-
serted into the chromosome of C. coli.
This genomic island is unique in several respects. First, it con-
tains genes encoding all known aminoglycoside-inactivating en-
zymes (AACs, ANTs, and APHs) and thus confers resistance to
multiple aminoglycoside antibiotics. Second, it is inserted into the
chromosome and is not associated with any known mobile ele-
ments or carried by a plasmid, suggesting that transmission is
likely mediated by homologous recombination. Third, the
genomic island was found in C. coli isolates that belong to three
clones as defined by PFGE and MLST analysis but was associated
with the high prevalence of aminoglycoside-resistant C. coli in
chickens in China, suggesting that this aminoglycoside resistance
island might have undergone spread by both horizontal gene
transfer and clonal expansion in the poultry production system in
Shandong province of China.
Previously, the gene cluster aadE–sat4–aphA-3 was detected
on plasmids such as pCG8245 in Campylobacter (9, 13). In the
genomic island identified in this study, all of the aminoglycoside
resistance genes encode constitute ORFs and thus are all presum-
ably functional. In contrast, the aadE gene in the aadE–sat4–
aphA-3 cluster and the aacA-aphD gene in pCG8245 were trun-
cated and not functional (13). aacA-aphD is the only identified
gene encoding a bifunctional aminoglycoside-modifying enzyme
responsible for both gentamicin and kanamycin resistance in
Campylobacter (13, 19). Identification of this gene in the genomic
island explains why the kanamycin-resistant C. coli isolates were
also resistant to gentamicin. To the best of our knowledge, this is
the first report of a chromosomal location of the gene aacA-aphD
and the gene cluster aadE–sat4–aphA-3 in Campylobacter. In
pCG8245, aadE–sat4–aphA-3was next to a hybrid of twoH. pylori
transposons, ISHp608 and IS606 (13); however, in the genomic
island identified in this study, no transposon-like elements were
found between cadF and COOl582. Based on these observations,
we speculate that the entire structure of the aminoglycoside resis-
tance genomic islandmight be derived from a pCG8245-like plas-
mid that lost its ability to replicate and was subsequently inte-
grated into the chromosome of C. coli by insertion.
FIG 4 PCR detection of the region between cadF and COO1582 in various
strains. Lanes 1 to 3, PCR products from kanamycin-susceptible isolates SX71,
SX73, and MH16, respectively; lanes 4 to 6, PCR products from aminoglyco-
side-resistant strains SX81, SX114, and MH57, respectively; lanes 7 to 9, PCR
products from theC. jejuni transformants of SX81, SX114, andMH57, respec-
tively; lane 10, PCR products from C. jejuni NCTC11168.
TABLE 4 MICs of aminoglycosides in the recipient and donor strains as well as transformantsa
Antimicrobial agent
MIC (mg/liter) for:
NCTC11168 SX81 NT81 NT1481 SX114 NT114 NT14114 MH57 NT57 NT1457
Streptomycin 8 512 512 512 512 512 512 512 512 512
Kanamycin 8 512 512 512 512 512 512 512 512 512
Gentamicin 1 128 256 256 256 256 256 256 256 256
Neomycin 2 32 32 32 64 64 64 32 32 32
Amikacin 4 32 32 32 32 32 32 64 64 64
a NT strains are transformants of C. jejuni 11168 with donor DNA from SX81 (NT81), SX114 (NT114), and MH57 (NT57). NT14 strains are transformants passaged in MH broth
in the absence of kanamycin.
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Interestingly, all six genes encoding aminoglycoside-modify-
ing enzymes identified in this study appear to have originated
fromGram-positive bacteria, includingEnterococcus, Staphylococ-
cus, and Pediococcus acidilactici. The aac, aacA-aphD, sat4, and
aphA3 genes showed 100% identity to their corresponding ho-
mologs, and the two aadE genes also showedmore than 97% iden-
tity to their Gram-positive homologs (Table 3). This observation
is consistent with previous findings by other investigators (6, 21)
and further suggests the transfer of antibiotic resistance genes be-
tween Gram-positive bacteria and Campylobacter. Additionally,
several hypothetical ORFs in the genomic island share high ho-
mologies with ORFs in Bacteroides dorei (Table 3), a Gram-nega-
tive organism. Together, these findings suggest that the genes in
the genomic island originated from divergent sources.
The C. coli isolates harboring the genomic island were from
two slaughterhouses located in two geographically separated areas
(SX andMH), suggesting the dissemination ofC. coli carrying this
aminoglycoside resistance island in different regions of Shandong
province in China. The antibiotic usage records in the two regions
indicated that aminoglycoside agents, such as neomycin, amika-
cin, and gentamicin, were commonly used for curing disease in
broiler chickens. This suggests that the emergence and spread of
aminoglycoside resistance in Campylobacter are likely driven by
the selection pressure from antibiotic usage. Based on the geno-
typing results from PFGE and MLST (Table 2 and Fig. 1), the C.
coli isolates carrying the antibiotic resistance island can be classi-
fied into three different clones. In Campylobacter, PFGE and
MLST are often used in combination to determine genetic relation-
ship, and isolates of the same PFGE type and ST are regarded as
clonal. Clone 1 isolates are PFGE subtype III and ST 1625, while
clones 2 and 3 are PFGE subtype I and ST 5604 and PFGE subtype II
and ST 1586, respectively. Clone 1 is predominant among the amin-
oglycoside-resistant isolates examined in this study, suggesting en-
demic spread of this clone in the broiler production system in Shan-
dong province of China. Furthermore, all three clones belong to
clonal complex 828,whichwas previously identified inC. coli isolates
from both humans and food-producing animals (23, 24).
The aminoglycoside resistance island identified inC. coli in this
study is no longer associatedwithmobile elements, but itmight be
disseminated via natural transformation mediated homologous
recombination. This possibility was demonstrated under labora-
tory conditions, in which the genes of the genomic island were
transferred from C. coli to C. jejuni and drastically increased ami-
noglycoside resistance in the recipient C. jejuni strain (Table 4).
This finding suggests that spread of this aminoglycoside resistance
island betweenC. coli andC. jejuni could occur in nature, asCam-
pylobacter species are naturally transformable. If this occurs, it will
pose a concern for public health, as C. jejuni is more frequently
associated with human campylobacteriosis than C. coli. Amin-
oglycoside antimicrobials, such as gentamicin, are used for treat-
ing systemic infections in humans caused by Campylobacter (2).
Although cases of systemic campylobacteriosis are rare, the clini-
cal consequences can be severe, as the infection may lead to bac-
teremia, abortion, or even neonatal death (20). Thus, transmis-
sion of aminoglycoside-resistant Campylobacter represents a
concern for food safety and public health.
In conclusion, this study provides the first report of a C. coli
genomic island that harbors genes conferring resistance to multi-
ple aminoglycoside antibiotics. This unique genomic island con-
sists of 14 ORFs and is disseminated amongC. coli isolates derived
from broiler chickens in China. Horizontal transfer and clonal
expansion of the aminoglycoside resistance island were observed,
which highlights the need for enhanced efforts to monitor the
spread of this genomic island in different Campylobacter species.
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